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 INTRODUCTION 
 Viral infections in the lower respiratory tract can be fatal. 
They not only cause cytopathic effects in infected cells within 
the airways, but also trigger cell infiltration into the lung tissue. 
This infiltration has to be tightly regulated in order to main-
tain gas exchange, suggesting that a delicate balance between 
an effective antiviral immune response and a life-threatening 
pathogenic reaction is essential to preserve the organ function 
while combating infection. 
 Human respiratory syncytial virus (RSV) is the major 
cause of serious lower respiratory tract infection in infants. 
Overexuberant and inappropriate immune responses have a 
major role in RSV disease 1 but the mechanisms leading to loss 
of immune regulation in the lungs of RSV-infected patients are 
not fully understood. Each year, RSV is estimated to cause 34 
million cases of lung infection, about 3.4 million hospitaliza-
tions, and the deaths of 66,000 – 199,000 children under 5 years 
of age. 2 Despite the acute and long-term effects of RSV infection 
in infants and adults there is still no vaccine available. 
 Regulatory T cells (Treg) have a crucial role in controlling 
immune responses; most are CD4   +   and express the transcrip-
tion factor Foxp3. In man, Treg deficiency causes dysregulated 
immunity with autoimmune disease affecting multiple organs. 3 
Tregs also regulate immune responses in allergy 4,5 and chronic 
infections, 6 and are thought to limit the extent of an inflamma-
tory response during viral infections. Studies of Friend virus 
infection demonstrate  in vitro suppression of CD8   +   T-cell func-
tion by virus-induced Tregs. 7 In this infection,  in vivo depletion 
of Tregs increases the antigen-specific CD8   +   T-cell responses 
and reduces viral burden. 8 In addition, Lund  et al. 9 reported that 
Tregs contribute to the establishment of protective immunity 
by inducing early antiviral immune response at the site of 
infection. Lung Tregs have a crucial role in the maintenance 
of self-tolerance and in the regulation of the immune response 
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to pathogens and commensals. In addition, studies suggest 
that Tregs have a key role in contributing to the maintenance 
of immune homeostasis in the airways. 10 However, the role 
and suppressive mode of action of Tregs in acute viral lung 
infections is less clear. 
 To determine if pulmonary immune responses are regulated 
by Tregs during acute viral infections, we compared the effects 
of Treg depletion and Treg boosting during experimental RSV 
infection in mice. We found that depletion of Tregs before RSV 
challenge led to a decreased viral load but markedly increased 
disease, characterized by weight loss, delayed recovery, and 
increased influx of inflammatory cells into the lung and airways. 
Conversely, boosting Treg numbers and activity by injecting 
interleukin (IL)-2 / anti-IL-2 immune complexes reduced patho-
logy but did not prevent viral clearance. Notably, the ability of 
Tregs to regulate lung inflammation during RSV infection criti-
cally depended on their ability to produce granzyme B (GzmB), 
a cytotoxic mediator normally associated with antiviral CD8   +  
T and natural killer (NK) cells. Thus, Tregs deploying a mecha-
nism normally associated with elimination of virus-infected cells 
are key effectors responsible for immune regulation in the lung 
during acute viral infection. 
 RESULTS 
 Loss of Tregs increases T-cell-driven lung inflammation 
and RSV disease severity 
 Bacterial artificial chromosome-transgenic  “ depletion of regu-
latory T cell ” (DEREG) mice express diphtheria toxin (DT) 
receptor and enhanced green fluorescent protein fusion protein 
under the control of the  foxp3 gene locus, allowing selective 
and efficient depletion of Foxp3   +   Treg cells by DT injection. 11 
BALB / c DEREG mice were depleted of Tregs by injection of DT 
intraperitoneally (i.p.) on day   −  2,   −  1, 2, 5, and 8 post infec-
tion with human RSV A2. Flow cytometric analysis confirmed 
the depletion of CD3   +   CD4   +   Foxp3   +   GFP   +   cells in the medi-
astinal lymph nodes, spleen, blood, and lung ( Supplementary 
Figure S1a online ). DT injections in the absence of infection 
of wild-type (WT) or DEREG mice did not cause neutrophil 
infiltration or any other detectable alterations in the lungs or 
airways ( Supplementary Figure S1b and c online ). As an index 
of disease severity, body weight was monitored daily in each 
individual mouse. BALB / c DEREG mice infected with RSV 
and depleted of Tregs showed increased and sustained weight 
loss and delayed recovery compared with control BALB / c mice 
( Figure 1a ). Treg depletion during RSV infection led to an 
increase in total cell numbers in the lung and bronchoalveo-
lar lavage fluid (BAL) on days 6 and 8 ( Figure 1c ) and day 14 
(data not depicted) post RSV infection. In the absence of Foxp3   +  
cells, a significant increase of CD4   +   Foxp3   −   T cells was seen 
in the lung (data not depicted) and BAL on day 6 and 8 post 
RSV infection ( Figure 1d ), which was maintained until day 14 
post infection (data not depicted). There was no difference in 
the expression of CD69 on CD4   +   Foxp3   −   T cells in the lung or 
BAL between control BALB / c mice and Treg-depleted DEREG 
mice after RSV infection (data not shown). In the BAL, a signi-
ficant increase of CD8   +   T cells was detected on day 6 and 8 
( Figure 1e and  Supplementary Figure S3c online ) with similar 
results in the lung (data not depicted and  Supplementary Figure 
S3c online ). Antigen-specific CD8   +   T cells, detected using M2-
specific pentamers, showed no increase on day 6 but increased 
at day 8 post RSV infection in Treg-depleted mice compared 
with control mice ( Figure 1e and  Supplementary Figure S4a 
and b online ). In addition, M2 peptide restimulation of lung or 
BAL cells on day 8 post infection increased interferon (IFN)-  
production by CD8   +   T cells in Treg-depleted mice ( Figure 1e 
and  Supplementary Figure S4b online ). Notably, Treg deple-
tion led to an increase in total numbers of macrophages and 
neutrophils on day 6 and 8 post RSV infection ( Figure 1f ), while 
no differences were detected on day 4 ( Figure 1f ) or 14 (data 
not depicted). Unexpectedly, ablation of Tregs also led to an 
influx of eosinophils in the BAL on day 8 ( Figure 1f ), which are 
normally not detected after primary infection but have been 
found after RSV infection of mice vaccinated with formalin-
inactivated RSV. 12 Depletion of Tregs caused no influx of neu-
trophils or eosinophils into the airways of uninfected DEREG 
mice, indicating that this response was specific to RSV infec-
tion ( Supplementary Figure S1b online ). In addition, a small 
increase of total numbers of dentritic cells in the lung (CD11c   +  
cells;  Supplementary Figure S2a online ) on day 4 and 8 was 
detected. Alveolar macrophages were excluded by gating out 
autofluorescent cells. Expression levels of CD80 on CD11c   +  
cells were elevated on day 6 and 8 ( Supplementary Figure S2b 
online ) while there was no change in the expression of CD86 
( Supplementary Figure S2b online ). 
 C57BL / 6J (B6) mice can be infected with human A2 RSV, 
but are relatively resistant to viral growth and weight loss. 13 
However, when Tregs were depleted in B6 DEREG mice, infec-
tion with RSV intranasally caused a striking weight loss of up to 
15 % by day 8 ( Supplementary Figure S3a online ). Furthermore, 
Treg depletion of B6 mice showed broadly similar effects to 
those shown in BALB / c mice ( Supplementary Figure S3b, c, 
and d online ). Furthermore, RSV infected, undepleted DEREG 
mice or B6 WT mice injected with DT did not show any differ-
ences from WT B6 mice infected with RSV ( Supplementary 
Figure S3 online ). 
 In summary, Treg depletion during RSV infection manifests 
itself in markedly increased recruitment of inflammatory cells 
to the lung and increases disease severity in both BALB / c and 
B6 mice. 
 Absence of Tregs accelerates T-cell effector function 
 Treg depletion led to decreased viral load in the lung on day 4 
post infection ( Figure 1b ), the peak of viral load in this infection 
model. 14 This suggests that in addition to dampening inflamma-
tion, Tregs inhibit early antiviral immunity. To investigate this 
further, we measured IFN-  and GzmB by intracellular staining 
of lung T cells from RSV-infected mice, with or without Treg 
depletion. GzmB was detected directly  ex vivo while IFN-  was 
detected after 3-h phorbol 12-myristate 13-acetate / ionomycin 
restimulation. Treg depletion greatly increased IFN-  and 
GzmB staining in CD8   +   and CD4   +   T cells in the lung on day 4 
post infection ( Figure 2 ). Therefore, we suggest that Tregs are 
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important for dampening the early activation of conventional 
T cells during RSV infection, thereby delaying viral clearance. 
 Lung Tregs express GzmB and can degranulate 
 Recent results using tumor models suggest that Tregs can medi-
ate immune control in part through GzmB-dependent cytotoxi-
city. 15,16 Consistent with this possibility, we found that Tregs 
in the lungs ( Figure 3a and b ) and airways (data not depicted) 
of RSV-infected mice expressed GzmB by day 8 post infection. 
GzmB   +   Tregs were not found in the draining lymph nodes either 
on day 4 or 8 post RSV infection, indicating that Treg production 
of GzmB was restricted to the lung tissue (data not depicted). 
 To test whether Tregs from the lungs of RSV-infected mice can 
degranulate upon T-cell receptor activation , we captured trans-
iently expressed CD107a on the cell surface with anti-CD107a 
antibodies following stimulation of lung-derived CD4   +   Foxp3   +  
T cells with anti-CD3 / CD28-coated beads  ex vivo ( Figure 3c ). 
Interestingly, after a 4-h restimulation, lung Tregs expressed 
as much surface CD107a   +   as CD8   +   cytotoxic T cells from the 
same tissue. Thus, Tregs requiring the expression of GzmB to 
Eosinophils
0 2 4 6 8 10 12 14
70
80
90
100
110
Days post infection
%
 O
rig
in
al
 w
e
ig
ht
CD4+ T cells
CD8+ T cells
Neutrophils
BAL
0 2 4 6 8
0
1
2
3
*
Days post infection
***
To
ta
l c
el
ls
 (x
10
6 )
Lung
0 2 4 6 8
0
6
12
Days post infection
*
To
ta
l c
el
ls
 (x
10
7 )
0 2 4 6 8
0
3
6
Days post infection
* *
BA
L 
ce
lls
 (x
10
5 )
0 2 4 6 8
0
1
2
3 ***
Days post infection
***
BA
L 
ce
lls
 (x
10
5 )
0 2 4 6 8
0
1
2
3 *
Days post infection
BA
L 
ce
lls
 (x
10
5 )
M2-specific
CD8+ T Cells
M2-specific CD8+
IFN−γ+ T Cells
0 2 4 6 8
0
2
4
Days post infection
***
BA
L 
ce
lls
 (x
10
5 )
0 2 4 6 8
0
3
6
Days post infection
***
***
BA
L 
ce
lls
 (x
10
5 )
0 2 4 6 8
0
3
6
Days post infection
***
BA
L 
ce
lls
 (x
10
4 )
RSV
DEREG/RSV/DT
Viral load
0 2 4 6 8
0.01
0.1
1
10
100
Days post infection
***
*
Vi
ra
l l
oa
d 
(x1
03
)
FF
U 
pe
r l
un
g
0 2 4 6 8
0
5
10
15
**
Days post infection
ns
BA
L 
ce
lls
 (x
10
5 )
Macrophages
 Figure 1   Depletion of Foxp3   +   cells decreases viral load, increases cellular influx into the lungs, and delays recovery during respiratory syncytial 
virus (RSV) infection. BALB / c mice or BALB / c depletion of regulatory T-cell (DEREG) mice were infected with 10 6 focus-forming units RSV intranasally 
(day 0). Where indicated, mice were injected intraperitoneally (days   −  2,   −  1, 2, 5, and 8) with 0.75   g diphtheria toxin (DT). Lungs and bronchoalveolar 
lavage fluid (BAL) were obtained from na ï ve mice (day 0) or 2, 4, 6, or 8 post RSV infection. ( a ) Illness was monitored daily by weight for 14 days after 
RSV infection; percentage of original weight is shown. ( b ) Viral titer (FFU) was measured in lungs by immuno-plaque assay (detection limit at 1,000 
FFU). ( c ) Total numbers of cells in the lung and BAL were enumerated in na ï ve or RSV-infected mice, with and without regulatory T-cell depletion. 
( d ) Total numbers of CD3   +   -gated CD4   +   Foxp3   −   in the BAL were quantified using flow cytometry. ( e ) Total numbers of CD3   +   -gated CD8   +   T cells, 
M2 pentamer   +   CD8   +   T cells, and M2 peptide-restimulated CD8   +   IFN-    +   T cells in the BAL were quantified using flow cytometry. ( f ) Total numbers 
of macrophages, neutrophils, and eosinophils in the BAL were quantified using differential cell counting of hematoxylin and eosin-stained cytospins 
slides. Error bars indicate the s.e.m. Graphs are representative of at least two independent experiments with four mice per group in each. NS, not 
significant. The significance of results between the groups was analyzed by two-tailed, unpaired Student’s  t test (* P < 0.05, ** P < 0.01, *** P < 0.001). 
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perform their regulatory function are recruited to the lungs dur-
ing acute RSV infection. 
 IL-2 complexes increase Treg frequencies and induce GzmB 
expression in lung Tregs 
 As the above experiments indicated that Tregs are crucial for 
the control of RSV infection, we tested the effect of enhancing 
their number and activity by injecting BALB / c mice i.p. with 
IL-2 immune complexes (IL-2 Cx) 17 for 3 days (days   −  2,   −  1, 
and 0). Examination of the spleen, mesenteric lymph nodes 
(mesLNs), and lung showed increased cellularity after IL-2 
Cx injections ( Supplementary Figure S5 online ), as well as 
increased frequencies of Tregs but not na ï ve CD3   +   CD4   +   or 
CD3   +   CD8   +   T cells ( Supplementary Figure S5 online and 
data not depicted). IL-2 Cx also expand NK cells 18 and the fre-
quency of NK cells increased significantly in the lung but not 
in the spleen or mesLNs on day 1 ( Supplementary Figure S5d 
online ) and day 5 (data not depicted) after IL-2 Cx injections. In 
addition to increased frequency, Tregs in IL-2 Cx-injected mice 
displayed an activated phenotype, including elevated expres-
sion of CD25, glucocorticoid-induced TNFR (GITR), cytotoxic 
T-lymphocyte antigen 4, and inducible T-cell co-stimulator 
(ICOS) ( Supplementary Figure S5c online ). Less marked 
increases were also seen in intracellular Foxp3, programed death 
receptor ligand 1 (PDL-1), CD69, and intercellular adhesion 
molecule 1 (ICAM-1). In contrast, CD44 and folate receptor 
4 (FR4) expression on lung Tregs were unaffected by IL-2 Cx 
injections. Interestingly, CD127 expression on Treg was strongly 
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 Figure 2   Foxp3   +   cells control early T-cell activation during respiratory syncytial virus (RSV) infection. CD3   +   -gated, CD8   +   T cells and CD4   +   Foxp3   −   
T cells from lungs on day 4 of RSV infection (with or without regulatory T-cell depletion) were analyzed by flow cytometry (filled symbols, first study; 
open symbols, repeat). ( a ) Representative contour plots and percentage of intracellular interferon (IFN)-  after  in vitro phorbol 12-myristate 13-acetate /
 ionomycin restimulation. ( b ) Representative histograms and mean fluorescence intensity (MFI) of granzyme B (GzmB) (solid lines), and isotype control 
staining (dotted lines) directly  ex vivo . Results from individual mice from two independent experiments are shown on the right. DEREG, depletion of 
regulatory T cell; DT, diphtheria toxin. The significance of results between the groups was analyzed by two-tailed, unpaired Student’s  t test (** P < 0.01, 
*** P < 0.001). 
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downregulated by IL-2 Cx injections ( Supplementary Figure 
S5c online ). Notably, downregulation of CD127 expression has 
previously been shown in human Tregs. 19 The activation status 
of the Tregs returned to basal levels by day 5 post last injection 
(data not depicted). 
 Lung NK cells had high expression of GzmB after IL-2 Cx 
injections ( Supplementary Figure 5e online ). Surprisingly, IL-2 
Cx injections also induced GzmB production by Tregs, which 
was detectable both in the lung and in the spleen ( Figure 4g 
and data not depicted). RSV infection further increased GzmB 
production by lung Tregs in IL-2 Cx-injected mice ( Figure 4g ). 
Thus, IL-2 Cx injections increase the numbers and activation 
status of Tregs and NK cells, and importantly induce GzmB 
production in lung Tregs. 
 Boosting Tregs limits lung inflammation 
 Treg boosting by IL-2 Cx has previously been shown to inhibit 
allergic airway disease, 20 EAE, and allograft rejection. 21 Thus, 
we examined whether IL-2 Cx injections had beneficial effects 
in RSV lung disease. We gave IL-2 Cx injections i.p on day 1, 
2, and 3 after RSV infection. As expected, weight loss in nor-
mal BALB / c mice infected with RSV peaked at day 6 and 7 
with recovery starting at day 8. In contrast, mice injected with 
IL-2 Cx showed accelerated recovery ( Figure 4a ), even though 
the viral titers were similar to those found in untreated mice 
( Figure 4b ). The total cell number in the BAL of IL-2 Cx-injected 
mice was significantly, although only slightly, decreased com-
pared with phosphate-buffered saline (PBS)-injected mice after 
RSV infection ( Figure 4c ). Furthermore, while CD4   +   Foxp3   −  
T cells did not change in numbers between IL-2 Cx-injected and 
PBS-injected mice ( Figure 4d ), CD8   +   effector T-cell popula-
tions were decreased in the lung on day 8 post infection in the 
RSV / IL-2 Cx mice ( Figure 4e ). This decrease was even more 
remarkable for antigen-specific CD8   +   T cells detected by M2 
pentamer staining or for IFN-  -producing CD8   +   T cells after 
M2 peptide restimulation ( Figure 4e ). To address the role of 
IL-2 Cx on other cytokines, we measured IL-10 production 
from T cells after RSV infection of IL-2 Cx- or PBS-injected 
mice. Production of IL-10 from CD4   +   or CD8   +   T cells in the 
BAL did not change after IL-2 Cx injections at day 4 but were 
slightly lower on day 8 post RSV infection ( Supplementary 
Figure S6 online ). To explore the activation status of effector T 
cells and NK cells in the airways after RSV infection and IL-2 
Cx injections, their GzmB expression was analyzed. Surprisingly, 
NK cells, CD4   +   and CD8   +   T cells from the RSV / IL-2 Cx 
mice showed a drastic decrease in the expression of GzmB on 
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Student’s  t test (** P < 0.01). 
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day 8 post infection compared with RSV mice ( Figure 4f ). In 
addition, the number of neutrophils in the BAL was decreased 
in the RSV / IL-2 Cx mice at day 8 post infection (data not 
depicted). 
 In order to test whether the expanded NK cells or Tregs were 
responsible for the decrease in lung inflammation, RSV / IL-2 Cx 
mice were additionally injected with rabbit anti-mouse asialo 
GM1 (anti-aGM1) or anti-CD25 antibody (PC61). Depletion 
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of NK cells with anti-aGM1 revealed that much of the GzmB 
in the BAL on day 4 post RSV infection was attributable to NK 
cells ( Supplementary Figure S7a online ). However, in IL-2 Cx-
injected mice, NK cell depletion had little effect on BAL GzmB 
levels at day 4 post infection, suggesting that Tregs might be an 
additional source of GzmB as shown previously ( Supplementary 
Figure S7a online and  Figure 3 and 4g ). In order to address the 
role of Tregs, RSV / IL-2 Cx mice were additionally injected with 
anti-CD25 antibody (PC61) on day   −  1 and 3 in order to elimi-
nate Tregs. Analysis of CD4   +   Foxp3   +   T cells in the lung on day 8 
post infection confirmed depletion ( Supplementary Figure S7b 
and d online ). Notably, depletion of CD25   +   cells reversed the 
effects of the IL-2 Cx injections, increasing total cell numbers in 
the lymph node and BAL, and promoting infiltration of CD8   +  
T cells into the lung ( Supplementary Figure S7c and d online ). 
This suggests that the effect of IL-2 Cx injections in our model 
is due to boosting of Tregs rather than NK cells, supporting the 
notion that  in vivo boosting of Tregs limits lung inflammation 
and disease severity during RSV infection. 
 Tregs influence the chemokine and cytokine production in 
the airways 
 Chemokine and cytokine expression has an important role in 
the recruitment and activation of different cell types during RSV 
infection. 22 To elucidate the role of Tregs in this process, we 
analyzed the BAL samples from na ï ve mice, WT, Treg-depleted 
DEREG, or IL-2 Cx-injected mice at different time points 
after RSV infection ( Figure 5 ). CXCL2, CCL5, IL-4, IL-10, 
IL-12p70, IL-13, IL-17, IL-21, IL-33, TNF-  , and TSLP could 
not be detected in any group at any time post RSV infection 
(data not depicted). In contrast, the levels of CCL11, CXCL10, 
CXCL9, CCL2, CCL3, IFN-  , IL-5, IL-6, and IL-9 were signif-
icantly increased in the lungs of RSV-infected mice that had 
been depleted of Tregs ( Figure 5 ). The converse was observed 
for CCL20, CXCL10, CXCL9, CCL3, CCL4, IFN-  , GzmB, and 
IL-9 in mice receiving IL-2 Cx ( Figure 5 ). Thus, removing Tregs 
was accompanied by an elevation of pro-inflammatory chem-
okine and cytokine levels in the airways. In contrast, boosting 
Tregs inhibited inflammation and decreased levels of these same 
chemokines and cytokines. 
 Tregs control acute RSV lung infection via GzmB 
 In order to test the possible role of GzmB in Treg suppression of 
lung inflammation, we attempted but failed to reconstitute Treg-
depleted DEREG mice with Tregs from wt or GzmB   −  /  −   mice. 
Therefore, we used an alternative approach and constructed 
mixed bone marrow (BM) chimeric mice 23 using C57BL / 6 hosts 
reconstituted with either 20 %  Gzmb   +  /  +   or  Gzmb  - / -  BM, and 
80 % DEREG BM. In such chimeras, Tregs of DEREG origin 
can be depleted by DT injection, leaving only WT  Gzmb   +  /  +   
or knockout  Gzmb  - / -  Tregs, respectively. If GzmB expression 
in Tregs has a fundamental role in regulating disease severity 
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 Figure 5   Foxp3   +   cells influence chemokine and cytokine production in the airways during respiratory syncytial virus (RSV) infection. 
Bronchoalveolar lavage fluid samples from BALB / c na ï ve mice, regulatory T cell (Treg)-depleted DEREG (depletion of regulatory T cell / diphtheria toxin 
(DT)), or IL-2 immune complexes-injected mice at different time points after RSV infection were analyzed for interferon (IFN)-  , granzyme B (GzmB), 
interleukin (IL)-5, IL-6, IL-9, CCL2, CCL3, CCL4, CCL11, CCL20, CXCL9, and CXCL10. Error bars indicate the s.e.m. Graphs show pooled data from 
two independent experiments with four mice per group in each. The significance of results between the groups was analyzed by two-tailed, unpaired 
Student’s  t test (* P < 0.05, ** P < 0.01, *** P < 0.001). 
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during acute viral lung infection, infection-associated pathology 
in mice that only have  Gzmb   −  /  −   Tregs should be more severe 
than in mice that contain  Gzmb   +  /  +   Tregs. 
 Control chimeras with 100 % DEREG BM with or without 
depletion of Tregs gave comparable results to those with non-chi-
meric mice. In these mice, DT injection led to a marked increase 
in weight loss, indicative of unabated pathological inflammation 
( Figure 6 and  Supplementary Figure 3 online ). This patho logy 
was rescued in DT-treated mice that had been reconstituted 
with 80 % DEREG and 20 %  Gzmb   +  /  +   BM, demonstrating that 
the 20 %  Gzmb   +  /  +   Tregs were sufficient to reconstitute regula-
tion. Strikingly, mice reconstituted with 80 % DEREG and 20 % 
 Gzmb   −  /  −   BM were not rescued and showed increased weight 
loss on day 6 and 7, similar to that seen in Treg-depleted mice 
that had been reconstituted with 100 % DEREG BM ( Figure 6a ). 
Mice with GzmB-deficient Tregs displayed greater inflammatory 
cell influx into the lungs and airways, and elevated total T-cell 
numbers of CD4   +   Foxp3   −   and CD8   +   T cells in the lung when 
compared with control chimeric mice ( Figure 6b and c ). In addi-
tion, total numbers of IFN-  -producing T cells were increased 
in the lungs and BAL of  Gzmb   −  /  −   Treg mice compared with 
 Gzmb   +  /  +   Treg mice ( Figure 6d and data not depicted). Thus, 
 Gzmb   −  /  −   Tregs are unable to control lung pathology indicating 
that the regulatory effect of lung Tregs during acute RSV infec-
tion is dependent on their ability to produce GzmB. 
 DISCUSSION 
 The regulatory mechanism for controlling immune responses 
and preventing immunopathology during acute viral lung infec-
tion remains poorly understood. We used two complementary 
 in vivo approaches to examine the contribution of Tregs in con-
trolling virally induced lung inflammation: depletion of Tregs 
(DEREG mice) and boosting of Tregs (by IL-2 Cx injections). 
Depletion of Tregs before RSV infection caused increased 
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 Figure 6   The regulatory function of Foxp3   +   cells during respiratory syncytial virus (RSV) infection is dependent on granzyme B (GzmB). C57BL / 6J 
mixed BM chimeric mice were infected with RSV intranasally (day 0), with or without 0.75  μ g diphtheria toxin (DT) intraperitoneally (days   −  2,  −  1, 2, 
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and sustained weight loss after infection, accompanied by an 
increase in inflammation and cell recruitment to the lung by day 
6. Importantly, the general increase in cell recruitment was not 
reflected in recruitment of virus-specific CD8   +   T cells on day 4 
or 6; only on day 8 was an enhanced virus-specific response evi-
dent in the lung and airway. Boosting Treg numbers and activ-
ity gave broadly opposite effect, diminishing inflammation but 
without affecting viral load. Together, these results underscore 
the key role of Tregs in determining the sequence of events and 
the final balance between effective antiviral immunity and con-
trolling harmful immunopathology. Notably, after a systematic 
analysis of the Treg expression profile, we found that Tregs in 
the lungs of RSV-infected mice expressed GzmB and that this 
expression is essential for their function. This suggests that, 
Tregs might be able to co-opt a program normally employed by 
cytotoxic T cells and NK cells in order to regulate lung inflam-
mation during acute viral infection. 
 We and others have recently shown that depletion of Tregs 
with anti-CD25 antibody enhances RSV-induced disease on 
day 8 and increases T-cell activation. 24 – 26 However, anti-CD25 
also depletes activated T cells and does not deplete Foxp3   +  
CD25   −   Tregs. In contrast, we now find that specific ablation of 
Foxp3   +   T cells during RSV infection in DEREG mice causes an 
increase in lung accumulation of effector T cells accompanied 
by a decrease in peak viral load. Our results are all the more 
striking as it is known that DT injection of DEREG mice does 
not fully deplete Tregs; some FoxP3   +   GFP   −   cells remain and 
can subsequently expand. 27 
 It has recently been shown that Tregs are essential for an early 
protective response in experimental herpes simplex virus infec-
tion of mice, enhancing effector cell recruitment into infected 
tissues, which promotes viral clearance. 9 In addition, Tregs can 
exert direct control over the proliferation of effector T cells, 28,29 
which may account for the increase in effector T cells in Treg-
depleted mice. This resembles the situation in acute Friend 
retrovirus infection, where Treg depletion decreases viral load 
while promoting elevated GzmB expression in CD8   +   T cells. 8 
It is likely that increased GzmB expression by T cells is directly 
responsible for the reduced viral load through cytolytic attack 
on infected cells. 30 
 Previous work has shown that, in addition to promoting viral 
clearance, CD4   +   and CD8   +   effector T cells are responsible for 
causing the weight loss and lung inflammation characteristic 
of RSV disease in mice. 30,31 Treg-depleted mice displayed an 
increase in weight loss and inflammatory cell infiltration into 
the lungs indicating that Tregs are essential for controlling the 
acute lung inflammation. Increased pro-inflammatory cytokine 
and chemokine levels were also indicative of greater lung and 
airway inflammation in Treg-depleted mice. We were surprised 
to find that depletion of Foxp3   +   T cells also caused an increase 
in the influx of neutrophils and eosinophils accompanied by 
elevated levels of inflammatory mediators IL-5, IL-9, CCL11, 
CXCL9, and CXCL10 in the airway on day 8 post RSV infection. 
This was not observed in the anti-CD25 depletion studies 24 – 26 
or during primary RSV infection of normal mice. 31 However, 
the absence of Tregs also enhances eosinophil infiltration into 
the airways during allergic airway inflammation and increases 
levels of IL-4, IL-5, and IL-13, 5 suggesting that Foxp3   +   T cells 
may directly or indirectly regulate granulocyte influx into the 
airways and also suppress a Th2-biased immune response. 
Together, these findings support a major role for Tregs in regu-
lating the immune response to lung infection both at the time of 
initiation of inflammation and at the peak of disease. 
 Boosting Tregs  in vivo by IL-2 Cx injections after acute viral 
lung infection limited lung inflammation and disease seve rity 
during RSV infection, which was accompanied by reduced 
cytokine and chemokine production in the BAL. IL-2 Cx injec-
tions also caused a marked increase in lung NK cell numbers 
and activation. However, when Tregs were depleted with anti-
CD25  mAb, IL-2 Cx injection no longer decreased RSV-associ-
ated lung pathology. This suggests that, even though NK cells 
can have an important role in viral clearance, 32,33 Tregs are the 
major mediators of the anti-inflammatory effect of IL-2 Cx 
during RSV infection. 
 Unexpectedly, we found that Tregs from the lung of RSV-
infected mice express intracellular GzmB and degranulate after 
stimulation  in vitro . GzmB expression by lung Tregs was also 
induced in mice injected with IL-2 Cx even in the absence of 
infection. Therefore, we speculate that the beneficial outcome of 
IL-2 Cx injections after RSV infection might be due to specific 
activation of GzmB-producing Tregs in the lung. To confirm 
that GzmB is essential for the regulatory function of Tregs in 
this model, we constructed mixed BM chimeric mice 23 using 
BM from DEREG mice (80 % ) and GzmB knockout mice (20 % ). 
Most cells (80 % ) in these chimeric mice are able to make GzmB 
but the Treg compartment is completely deficient in GzmB upon 
treatment with DT. As controls, we used chimeric mice with 80 % 
DEREG and 20 % WT BM. Chimeric mice with GzmB-deficient 
Tregs showed a very similar phenotype to fully Treg-depleted 
mice, exhibiting marked weight loss and increased lung inflam-
mation. 
 These results reveal a crucial, cell-intrinsic, and unprecedented 
role for GzmB in the regulation of lung inflammation by Tregs 
during acute viral lung infection. In some tumor and transplan-
tation models, Tregs have been suggested to kill dendritic cells 
or CD8   +   T cells via perforin, GzmB, or Fas-FasL-dependent 
mechanisms. 16,34 – 38 It is therefore possible that the require-
ment for GzmB in the Treg compartment during RSV infec-
tion reflects a cytolytic mode of regulation. Notably, there are 
also extracellular non-cytolytic functions of the serene protease 
GzmB. 39 GzmB cleaves aspartic acid residues (aspartase activ-
ity) and accumulates in extracellular fluids. Additionally, GmzB 
works together with perforin to kill cells, 40 but works without 
perforin to cleave the proteoglycan decorin in the extracellular 
space. 41 Whichever the mechanism, our unexpected finding of 
a requirement for GzmB   +   Tregs in the lung and airways during 
RSV infection is unlikely to be restricted to this model. As such, 
it may represent a general aspect of immunity during infections 
of the respiratory tract and other delicate barrier sites. 
 Interestingly, Bem  et al. 42 have reported elevated GzmB 
expression in CD4   +   T cells in the BAL from children 
with severe RSV infection. In addition, many children with 
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haemophagocytic lymphohistiocytosis (a rare immune dys-
regulation syndrome) have genetic mutations in the perforin /
 granzyme pathway. Haemophagocytic lymphohistiocytosis is 
characterized by an uncontrolled immune response, especially 
to viral infections. 43 The results reported here raise the possibil-
ity that lack of GzmB production by Tregs in haemophagocytic 
lymphohistiocytosis leads to impaired immune regulation, and 
suggest that our findings could be directly relevant to human 
disease. 
 Our work raises a number of interesting issues for future 
studies. For example, what signals are regulating GzmB expres-
sion in Tregs in the lung and is the Treg role antigen specific? 
Nevertheless, even without knowing the answer to these ques-
tions we speculate that selectively enhancing GzmB-expressing 
Tregs could potentially be used as a therapeutic strategy in acute 
viral lung infections, dampening inflammation without elevat-
ing viral load. Our demonstration that Tregs have a pivotal role 
in controlling lung inflammation and the identification of a role 
for GzmB in the  in vivo function of lung Tregs are important 
steps in elucidating the mechanisms by which the fine balance 
between clearing virus and controlling immune responses is 
achieved, so allowing the gas exchange function of the lung to 
be maintained in the face of viral attack. 
 METHODS 
 Mice, virus stocks, and infection.  Six- to ten-week-old C57BL / 6 or 
BALB / c mice (Harlan, Blackthorn, UK) were maintained in patho-
gen-free conditions under UK Home Office guidelines. DEREG mice 
on C57BL / 6 or BALB / c background, and C57BL / 6  Gzmb   −  /  −   (Jackson, 
Bar Harbor, ME 11,44 ) were used in the study. 
 Plaque-purified human RSV (A2 strain from the ATCC, Teddington, 
UK) was grown in HEp-2 cells. 26 Age- and sex-matched mice were lightly 
anesthetized and infected intranasally with 10 6 focus-forming units 
(FFU) RSV in 100   l. 
 Foxp3   +   cell depletion, IL-2 complex injections, NK cell and CD25 
depletion.  DEREG mice were injected with 0.75   g of DT (Merck, 
Feltham, UK) in PBS i.p. on days   −  2 and   −  1, and on days 2, 5, and 8 
after RSV infection to induce and maintain Foxp3   +   T-cell depletion. 
IL-2 Cx were obtained by mixing 1   g rmIL-2 (Peprotech, Rocky Hill, 
NJ) and 5   g anti-IL-2 (Clone JES6-1A12; eBioscience, San Diego, CA), 
and incubating at 37 ° C for 30  min. Age- and sex-matched BALB / c or 
C57BL / 6 mice received daily i.p. injections of IL-2 Cx or PBS for three 
consecutive days. In some experiments, mice were additionally injected 
i.p. with 50   l of rabbit anti-mouse asialo GM1 on days   −  2, 0, and 3 
(Dako, Osaka, Japan), or with 200   l of anti-CD25 antibody (PC61; 
1  mg  ml   −  1 ) on days   −  1 and 3. 
 BM chimeras.  C57BL / 6 recipient mice were lethally irradiated 
(1000  rad   irradiation). On the same day, 3 × 10 6 BM cells from C57BL / 6 
DEREG BM were injected intravenously into the irradiated recipients. 
Reconstitution determined as GFP   +   Tregs was 90 – 95 % after 10 – 12 
weeks. To obtain mixed BM chimeras in which the Tregs are GzmB defi-
cient, we reconstituted irradiated C57BL / 6 hosts with BM from  Gzmb   −  /  −   
(20 % ) and DEREG mice (80 % ). Thus, 80 % of the Tregs can be depleted 
and the remaining Tregs are GzmB deficient, while 80 % of the non-Treg 
cells are of WT origin. Control C57BL / 6 hosts were reconstituted with 
WT BM (20 % ) and DEREG BM (80 % ). 
 Cell collection and preparation.  Bronchoalevolar lavage (BAL) was 
carried out using 1  ml PBS containing 12  m M Lidocaine by flush-
ing three times. In order to obtain single-cell suspensions, lungs were 
processed with the gentleMax dissociator (Miltenyi Biotech, Surrey, UK) 
using Collagenase D (50   g  ml   −  1 , Sigma, Dorset, UK). Total cell counts 
were determined by flow cytometry using Count Bright counting beads 
(Invitrogen, Paisley, UK), and dead cells were excluded by staining for 
7-amino-actinomycin D (7-AAD, Sigma). For determination of cellu-
lar composition in the BAL, cells were transferred onto a microscope 
slide (Thermo Scientific, Braunschweig, Germany) using a cytospin 
centrifuge, and stained with hematoxylin and eosin (Reagena, Gamidor, 
Didcot, UK). 
 Flow cytometry.  For flow analysis, the LIVE / DEAD Fixable Red Dead 
cell stain kit (Invitrogen) was used to exclude dead cells. Cells were incu-
bated with Fc  III / II receptor antibody (BD Biosciences, Oxford, UK), 
and were labeled with the following antibodies (from BD Biosciences 
unless otherwise stated): V450-conjugated anti-mNKp46 / NCR1, 
FITC-conjugated anti-FR4 (12A5, Biolegend, San Diego, CA), PE-
Cy7-conjugated anti-CD3 (145-2C11), Pacific Blue or conjugated 
anti-CD4 (RM4-5), Alexa Fluor 700-conjugated anti-CD8  (53-6.7), 
PE-conjugated anti-CD25 (PC61), FITC-conjugated anti-CD44 (IM7), 
PE-conjugated anti-CD69 (H1.2 F3), FITC-conjugated anti-CTLA-4 
(UC10-4F10-11), PE-conjugated anti-GITR (DTA-1), FITC-conjugated 
anti-CD127 (SB / 199), PE-conjugated anti-ICOS (7E.17G9), FITC-con-
jugated anti-PDL-1 (MIH5), FITC-conjugated anti-CD19 (6D5), Alexa 
Fluor 700-conjugated anti-CD11c (HL3), PE-conjugated anti-CD86 
(GL1), FITC-conjugated anti-CD80 (16-10A1), PE-conjugated MHC I 
Pentamer H-2Kd SYIGSINNI (M2; Proimmune, Oxford, UK), and PE-
conjugated anti-ICAM-1 (3E2). Tregs were discriminated by staining for 
Pacific Blue-conjugated anti-CD4 (RM4-5) and Foxp3 through green flu-
orescent protein expression from DEREG mice. Intracellular staining for 
Foxp3, APC, or FITC-conjugated anti-Foxp3 (FJK-16  s, eBioscience), and 
APC-conjugated anti-human GzmB (GB12, Caltag, Buckingham, UK; 
Invitrogen) was performed using the Foxp3 staining kit (eBioscience) 
following the manufacturer ’ s recommendations without restimulation. 
The anti-human GzmB antibody cross-reacts with mouse GzmB. 45 In 
order to detect intracellular IFN-  production, cells were stimulated with 
100  ng  ml   −  1 phorbol 12-myristate 13-acetate and 1   g  ml   −  1 ionomycin 
or 5   g  ml   −  1 M2 peptide (82 – 90, SYIGSINNI, Proimmune) in complete 
RPMI. After 1  h incubation, monensin (Golgi Stop, BD Biosciences) was 
added. Following 2 additional hours of incubation, cell surface staining 
was followed by intracellular cytokine and Foxp3 staining with APC anti-
IL-10 (JES5-16E3, eBioscience), Percp Cy 5.5 anti-IFN-  , and FITC-
conjugated anti-Foxp3 using the Foxp3 staining kit (eBioscience). The 
peptide restimulation was performed for 6  h and monensin was added 
for the last 4  h. Cells were acquired on a LSR II (BD Biosciences) with data 
analyzed using Flow Jo software (Ashland, OR). Cells were gated for live 
cells, singlets, and lymphocytes before analysis for indicated markers. 
 Degranulation assay.  Lungs from RSV-infected mice were processed on 
day 8 post infection as previously described, and sorted for CD4   +   T cells 
with the CD4 negative selection kit (Miltenyi Biotech). T cells (5 × 10 5 ) 
were restimulated with anti-CD3 / CD28-coated beads (Dynabeads, 
Invitrogen) for 4  h in the presence of anti-CD107a (1D4B, eBioscience) 
and GolgiStop (BD Biosciences) in 96-well, V-bottom plates. The LIVE /
 DEAD Fixable Red Dead cell stain kit was used to exclude dead cells. 
After restimulation, the cells were stained with anti-CD107a, anti-CD4, 
and anti-CD8. 38 Intracellular cytokine and Foxp3 staining with anti-
human GzmB and anti-Foxp3 was performed as described above. 
 Chemokine and cytokine detection.  Chemokines and cytokines were 
quantified by a 24-plex Luminex kit performed according to the manu-
facturer ’ s instructions (Biolegend), and data acquired with a Luminex 
100 (Applied Cytometry systems, Sheffield, UK). The concentration 
of cytokines in each sample was determined according to the standard 
curve using the software Starstation (Applied Cytometry Systems). In 
some experiments, GzmB levels in the BAL were measured by enzyme-
linked immunosorbent assay following manufacturer ’ s recommenda-
tions (R & D Systems, Abingdon, UK). 
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 Immuno-plaque assay.  RSV titer was assessed in lungs post RSV infec-
tion. Lung homogenate was titrated on HEp-2 cell monolayers in 96-well, 
flat-bottom plates. Twenty-four hours after infection, monolayers were 
washed, fixed with methanol, and incubated with biotin-conjugated goat 
anti-RSV antibody (Biogenesis, Poole, UK). Infected cells were detected 
using Streptavidin (Sigma) and DAB substrate (diaminobezindine tetra-
hydrochloride), and FFU enumerated by light microscopy. 
 Statistical analysis.  Results are presented as means ± s.e.m. The signifi-
cance of results between the groups was analyzed by two-tailed, unpaired 
Student ’ s  t -test ( * P  <  0.05,  * * P  <  0.01,  * * * P  <  0.001). Values of  P  <  0.05 
were considered significant (Prism software; Graph-Pad Software, 
La Jolla, CA). 
 SUPPLEMENTARY MATERIAL is linked to the online version of the 
paper at  http://www.nature.com/mi 
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